FMNL1 and glioblastoma: In the study of Higa et al., FMNL1 expression was examined by immunohistochemistry in tissue samples of 217 cases of glioblastoma, and as a result of the study, it was explained that high FMNL1 levels were an indicator of poor prognosis and low survival, and that FMNL1 silencing blocked cell migration and invasion in glioblastoma by suppressing actin polymerization.